NCT04701177View on ClinicalTrials.gov

Digitally-enhanced, Decentralized, Multi-omics Observational Cohort

Enrolling by invitationOBSERVATIONAL
Enrollment

100,000

Participants

Timeline

Start Date

March 15, 2021

Primary Completion Date

October 30, 2031

Study Completion Date

November 30, 2031

Conditions
Presymptomatic DiseaseMild Cognitive ImpairmentMemory Loss (Excluding Dementia)Cognitive ChangeDementiaAlzheimer DiseaseParkinson's Disease and Parkinsonism
Interventions
DIAGNOSTIC_TEST

AltoidaML

Computerized Complex Instrumental Activities of Daily Living Marker (NMI) (AltoidaML). ClinicalTrials.gov Identifier: NCT02843529

Trial Locations (4)

25314

BRNX clinic, affiliated with Dubai Health Authority, Dubai

49100

Ionian University, Corfu

54643

Panhellenic Federation Of Alzheimer's Disease And Related Disorders, Thessaloniki

55250

Greek Alzheimer's Association and Related Disorders, Thessaloniki

All Listed Sponsors
collaborator

Ionian University

OTHER

collaborator

Greek Alzheimer's Association and Related Disorders

OTHER

collaborator

Panhellenic Federation Of Alzheimer's Disease And Related Disorders

UNKNOWN

collaborator

Dubai Health Authority

OTHER_GOV

lead

Greece 2021 Committee

OTHER_GOV